Secondary prevention of gastric cancer: merging the endoscopic atrophic border with OLGA staging

Affiliations

¹ Veneto Tumor Registry, Padova, Italy; Department of Medicine DIMED Pathology and Cytopathology Unit, University of Padova, Padova, Italy.
² DIMED, University of Padova School of Medicine and Surgery, Padova, Italy.
³ Medicine (111D), Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
⁴ Pathology, Veterans Affairs North Texas Health Care System, Dallas, Texas, USA.

Comment

Massimo Rugge et al. Gut. 2020 Jun.

. 2020 Jun;69(6):1151-1152.

doi: 10.1136/gutjnl-2019-319107. Epub 2019 Jun 11.

¹ Veneto Tumor Registry, Padova, Italy; Department of Medicine DIMED Pathology and Cytopathology Unit, University of Padova, Padova, Italy.
² DIMED, University of Padova School of Medicine and Surgery, Padova, Italy.
³ Medicine (111D), Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
⁴ Pathology, Veterans Affairs North Texas Health Care System, Dallas, Texas, USA.

No abstract available

Keywords: gastric diseases; gastric inflammation; gastric pre-cancer; helicobacter pylori infection.

Conflict of interest statement

Competing interests: None declared.

Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients.
Rugge M, Meggio A, Pravadelli C, Barbareschi M, Fassan M, Gentilini M, Zorzi M, Pretis G, Graham DY, Genta RM. Rugge M, et al. Gut. 2019 Jan;68(1):11-17. doi: 10.1136/gutjnl-2017-314600. Epub 2018 Jan 6. Gut. 2019. PMID: 29306868
Do subjects with mild or moderate atrophic gastritis or intestinal metaplasia confined to the antrum benefit from gastric cancer surveillance?
Quach DT, Hiyama T, Gotoda T. Quach DT, et al. Gut. 2020 May;69(5):968-969. doi: 10.1136/gutjnl-2019-318720. Epub 2019 Apr 27. Gut. 2020. PMID: 31030192 No abstract available.